India  

Vaccination drive: Fewer takers for Covaxin among healthcare workers

IndiaTimes Thursday, 21 January 2021
0
shares
ShareTweetSavePostSend
 
Video Credit: ANI - Published
News video: TN Health Min takes Bharat Biotech's Covaxin shot in Chennai

TN Health Min takes Bharat Biotech's Covaxin shot in Chennai 01:28

The Health and Family Welfare Minister of Tamil Nadu, Dr C Vijayabaskar took Bharat Biotech's Covaxin shot. He took the shot in Chennai on morning of January 22. Dr C Vijayabaskar requested all to get vaccinated and safeguard themselves from COVID-19 pandemic. Billed as the world's largest...

You Might Like


💡 newsR Knowledge: Other News Mentions

BBV152 BBV152 Vaccine against COVID-19

Use entire national capacity to step up Covid vaccine production, PM tells officials

The PM’s directive came at a review meeting on the Covid situation on Saturday a day after he had overseen an assessment of oxygen supplies and production and..
IndiaTimes

Covaxin production to be increased to 100 million doses per month by September 2021: Centre

Union health minister Harsh Vardhan said financial support is being provided to four manufacturers to expand Covaxin vaccine production.
DNA

India to increase Covaxin production to 100 million doses per month by September

The Union government on Friday said it will amp up the production of the indigenously developed Covaxin vaccine to 100 million doses per month by September. As..
IndiaTimes
Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin [Video]

Mumbai's Haffkine Institute gets Centre's nod to produce Covaxin

The Central Government has given permission to Haffkine Institute to produce Bharat Biotech's Covaxin. CM Uddhav Thackeray thanked PM Modi through a tweet by CM office, Maharashtra on April 15, "The Dept of Science and Technology, Government of India, has granted approval to Haffkine Institute to produce Bharat Biotech's Covaxin vaccine on a transfer of technology basis. CM Uddhav Balasaheb Thackeray has thanked the Hon'ble PM Shri@narendramodi for approving this request."

Credit: ANI    Duration: 01:14Published

Related videos from verified sources

‘Unrelated’: Centre clarifies on 3 out of 4 deaths post Covid-19 vaccination [Video]

‘Unrelated’: Centre clarifies on 3 out of 4 deaths post Covid-19 vaccination

Union Health Ministry commented on the deaths post the covid-19 vaccination. Additional secretary said that 3 out of 4 deaths were unrelated to vaccination. In total 7.86 lakh healthcare workers have..

Credit: HT Digital Content     Duration: 01:47Published
Coronavirus: India is providing Covid-19 vaccines to these countries | Oneindia News [Video]

Coronavirus: India is providing Covid-19 vaccines to these countries | Oneindia News

India, one of the world's leading drugmakers, on Tuesday said it will provide COVID-19 vaccines under grant assistance to Bhutan, Maldives, Bangladesh, Nepal, Myanmar and Seychelles from Wednesday, and..

Credit: Oneindia     Duration: 01:04Published
2nd day of COVID vaccination drive begins at Bhubaneswar's Capital Hospital [Video]

2nd day of COVID vaccination drive begins at Bhubaneswar's Capital Hospital

The second day of COVID-19 vaccination drive began in Odisha's Bhubaneswar. It began for the healthcare workers at Capital Hospital on January 18 amid pandemic. Billed as the world's largest..

Credit: ANI     Duration: 02:00Published

Related news from verified sources

Covaxin generated excellent safety data, says Bharat Biotech

Amid the criticism of the Drug Controller General of India (DCGI) for granting approval for emergency use of Covid-19 vaccine Covaxin, its manufacturer Bharat...
Mid-Day Also reported by •IndiaTimes

Bharat Biotech gets permission to manufacture Covaxin for sale

The Central Licensing Authority on Sunday granted permission to Hyderabad-based Bharat Biotech to manufacture 'Covaxin' for sale and distribution, after the...
Mid-Day Also reported by •IndiaTimesHinduDNA

'Covaxin is 200% safe': Bharat Biotech MD says Covaxin 'being targeted for being Indian company's product'

Bharat Biotech MD Krishna Ella on Tuesday refuted criticism surrounding his company's coronavirus vaccine saying that Covaxin is "200% safe" and it is being...
IndiaTimes